Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice

10.18632/oncotarget.442

Saved in:
Bibliographic Details
Main Authors: Guo, Ke, Tang, Jing Ping, Jie, Li, Al-Aidaroos, Abdul Qader O, Hong, Cheng William, Tan, Cheng Peow Bobby, Park, Jung Eun, Varghese, Leyon, Feng, Zhiwei, Zhou, Jianbiao, Chng, Wee Joo, Zeng, Qi
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Language:English
Published: IMPACT JOURNALS LLC 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/203816
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-203816
record_format dspace
spelling sg-nus-scholar.10635-2038162022-10-10T04:03:01Z Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice Guo, Ke Tang, Jing Ping Jie, Li Al-Aidaroos, Abdul Qader O Hong, Cheng William Tan, Cheng Peow Bobby Park, Jung Eun Varghese, Leyon Feng, Zhiwei Zhou, Jianbiao Chng, Wee Joo Zeng, Qi CANCER SCIENCE INSTITUTE OF SINGAPORE DEAN'S OFFICE (MEDICINE) YONG LOO LIN SCHOOL OF MEDICINE Science & Technology Life Sciences & Biomedicine Oncology Cell Biology PRL-3 monoclonal antibody PRL-3 mouse/human chimeric antibody antibody therapy intracellular oncoprotein MONOCLONAL-ANTIBODIES TYROSINE-PHOSPHATASE METASTASIS MARKERS 10.18632/oncotarget.442 ONCOTARGET 3 2 158-171 United States 2021-10-19T07:25:36Z 2021-10-19T07:25:36Z 2012-02-01 2021-10-19T07:14:57Z Article Guo, Ke, Tang, Jing Ping, Jie, Li, Al-Aidaroos, Abdul Qader O, Hong, Cheng William, Tan, Cheng Peow Bobby, Park, Jung Eun, Varghese, Leyon, Feng, Zhiwei, Zhou, Jianbiao, Chng, Wee Joo, Zeng, Qi (2012-02-01). Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice. ONCOTARGET 3 (2) : 158-171. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.442 19492553 https://scholarbank.nus.edu.sg/handle/10635/203816 en IMPACT JOURNALS LLC Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
Cell Biology
PRL-3 monoclonal antibody
PRL-3 mouse/human chimeric antibody
antibody therapy
intracellular oncoprotein
MONOCLONAL-ANTIBODIES
TYROSINE-PHOSPHATASE
METASTASIS
MARKERS
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
Cell Biology
PRL-3 monoclonal antibody
PRL-3 mouse/human chimeric antibody
antibody therapy
intracellular oncoprotein
MONOCLONAL-ANTIBODIES
TYROSINE-PHOSPHATASE
METASTASIS
MARKERS
Guo, Ke
Tang, Jing Ping
Jie, Li
Al-Aidaroos, Abdul Qader O
Hong, Cheng William
Tan, Cheng Peow Bobby
Park, Jung Eun
Varghese, Leyon
Feng, Zhiwei
Zhou, Jianbiao
Chng, Wee Joo
Zeng, Qi
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
description 10.18632/oncotarget.442
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Guo, Ke
Tang, Jing Ping
Jie, Li
Al-Aidaroos, Abdul Qader O
Hong, Cheng William
Tan, Cheng Peow Bobby
Park, Jung Eun
Varghese, Leyon
Feng, Zhiwei
Zhou, Jianbiao
Chng, Wee Joo
Zeng, Qi
format Article
author Guo, Ke
Tang, Jing Ping
Jie, Li
Al-Aidaroos, Abdul Qader O
Hong, Cheng William
Tan, Cheng Peow Bobby
Park, Jung Eun
Varghese, Leyon
Feng, Zhiwei
Zhou, Jianbiao
Chng, Wee Joo
Zeng, Qi
author_sort Guo, Ke
title Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
title_short Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
title_full Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
title_fullStr Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
title_full_unstemmed Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
title_sort engineering the first chimeric antibody in targeting intracellular prl-3 oncoprotein for cancer therapy in mice
publisher IMPACT JOURNALS LLC
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/203816
_version_ 1749178751194759168